Abstract 4346086: Sex differences in the outcomes of rheumatic mitral stenosis in multicenter registry

Abstract

Background: While sex differences have been observed in various valvular heart diseases, data on rheumatic mitral stenosis, the most common form globally, remain limited. Objective: We sought to determine sex differences in rheumatic mitral stenosis (MS). Methods: From the 3,140 patients in the Multicenter MitrAl STEnosis with Rheumatic etiology (MASTER) registry in South Korea between January 2001 and December 2020, 2,631 patients who were diagnosed with moderate or severe rheumatic MS were included, after excluding those who had undergone prior mitral valve (MV) intervention. Patients were categorized by sex, and we compared demographics, echocardiographic data, and clinical outcomes, including all-cause death, heart failure hospitalization, MV intervention, and ischemic stroke. Results: Among the total population (n=2,631), 74.1% (n=1,950) were women. Compared to men, women were older (60.4 ± 13.0 vs. 58.5 ± 12.2, p<0.001), had a lower prevalence of atrial fibrillation (AF) (50.6 vs. 63.1%, p<0.001), a lower mean diastolic pressure gradient (6.8 ± 3.7 vs. 7.3 ± 4.1 mmHg, p=0.009), and a smaller left ventricular mass index (96.5 ± 29.0 vs. 107.1 ± 34.0 ml/m 2 ). All-cause mortality, heart failure hospitalization, and MV intervention rates were similar between the sexes. However, women had a significantly higher incidence of ischemic stroke compared to men (log-rank p=0.007, Figure 1 ). This finding remained consistent in propensity-matched analysis (p=0.007, Figure 2 ) after adjusting for clinical and echocardiographic variables, including AF. Conclusion: Women with moderate to severe MS had a higher risk of ischemic stroke compared with men. These findings might suggest the need for sex-specific anticoagulation strategies in the management of rheumatic MS.